Cargando…
Postlactational involution biomarkers plasminogen and phospho-STAT3 are linked with active age-related lobular involution
PURPOSE: Breast terminal duct lobular units undergo two distinctive physiological processes of involution: age-related lobular involution (LI), which is gradual and associated with decreased breast cancer risk, and postlactational involution, which is relatively precipitous, occurs with weaning, and...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5645446/ https://www.ncbi.nlm.nih.gov/pubmed/28752190 http://dx.doi.org/10.1007/s10549-017-4413-3 |
_version_ | 1783271892787920896 |
---|---|
author | Stallings-Mann, Melody L. Heinzen, Ethan P. Vierkant, Robert A. Winham, Stacey J. Hoskin, Tanya L. Denison, Lori A. Nassar, Aziza Hartmann, Lynn C. Visscher, Daniel W. Frost, Marlene H. Sherman, Mark E. Degnim, Amy C. Radisky, Derek C. |
author_facet | Stallings-Mann, Melody L. Heinzen, Ethan P. Vierkant, Robert A. Winham, Stacey J. Hoskin, Tanya L. Denison, Lori A. Nassar, Aziza Hartmann, Lynn C. Visscher, Daniel W. Frost, Marlene H. Sherman, Mark E. Degnim, Amy C. Radisky, Derek C. |
author_sort | Stallings-Mann, Melody L. |
collection | PubMed |
description | PURPOSE: Breast terminal duct lobular units undergo two distinctive physiological processes of involution: age-related lobular involution (LI), which is gradual and associated with decreased breast cancer risk, and postlactational involution, which is relatively precipitous, occurs with weaning, and has been associated with potentiation of tumor aggressiveness in animal models. Here we assessed whether markers of postlactational involution are associated with ongoing LI in a retrospective tissue cohort. METHODS: We selected 57 women from the Mayo Clinic Benign Breast Disease Cohort who underwent multiple biopsies and who were average age 48 at initial biopsy. Women were classified as having progressive or non-progressive LI between initial and subsequent biopsy. Serial tissue sections were immunostained for plasminogen, matrix metalloproteinase 9 (MMP-9), phospho-STAT3 (pSTAT3), tenascin C, Ki67, CD44, cytokeratin 14 (CK14), cytokeratin 19 (CK19), and c-myc. All but Ki67 were digitally quantified. Associations between maximal marker expression per sample and progressive versus non-progressive LI were assessed using logistic regression and adjusted for potential confounders. RESULTS: While no biomarker showed statistically significant association with LI progression when evaluated individually, lower expression of pSTAT3 (OR 0.35, 95% CI 0.13–0.82, p = 0.01) and higher expression of plasminogen (OR 2.89, 95% CI 1.14–8.81, p = 0.02) were associated with progressive LI in models simultaneously adjusted for all biomarkers. Sensitivity analyses indicated that the strengthening in association for pSTAT3 and plasminogen with progressive LI was due to collinearity between these two markers. CONCLUSIONS: This is the first study to identify biomarkers of active LI. Our findings that plasminogen and pSTAT3 are significantly associated with LI suggest that they may represent signaling nodes or biomarkers of pathways common to the processes of postlactational involution and LI. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s10549-017-4413-3) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5645446 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-56454462017-10-27 Postlactational involution biomarkers plasminogen and phospho-STAT3 are linked with active age-related lobular involution Stallings-Mann, Melody L. Heinzen, Ethan P. Vierkant, Robert A. Winham, Stacey J. Hoskin, Tanya L. Denison, Lori A. Nassar, Aziza Hartmann, Lynn C. Visscher, Daniel W. Frost, Marlene H. Sherman, Mark E. Degnim, Amy C. Radisky, Derek C. Breast Cancer Res Treat Preclinical Study PURPOSE: Breast terminal duct lobular units undergo two distinctive physiological processes of involution: age-related lobular involution (LI), which is gradual and associated with decreased breast cancer risk, and postlactational involution, which is relatively precipitous, occurs with weaning, and has been associated with potentiation of tumor aggressiveness in animal models. Here we assessed whether markers of postlactational involution are associated with ongoing LI in a retrospective tissue cohort. METHODS: We selected 57 women from the Mayo Clinic Benign Breast Disease Cohort who underwent multiple biopsies and who were average age 48 at initial biopsy. Women were classified as having progressive or non-progressive LI between initial and subsequent biopsy. Serial tissue sections were immunostained for plasminogen, matrix metalloproteinase 9 (MMP-9), phospho-STAT3 (pSTAT3), tenascin C, Ki67, CD44, cytokeratin 14 (CK14), cytokeratin 19 (CK19), and c-myc. All but Ki67 were digitally quantified. Associations between maximal marker expression per sample and progressive versus non-progressive LI were assessed using logistic regression and adjusted for potential confounders. RESULTS: While no biomarker showed statistically significant association with LI progression when evaluated individually, lower expression of pSTAT3 (OR 0.35, 95% CI 0.13–0.82, p = 0.01) and higher expression of plasminogen (OR 2.89, 95% CI 1.14–8.81, p = 0.02) were associated with progressive LI in models simultaneously adjusted for all biomarkers. Sensitivity analyses indicated that the strengthening in association for pSTAT3 and plasminogen with progressive LI was due to collinearity between these two markers. CONCLUSIONS: This is the first study to identify biomarkers of active LI. Our findings that plasminogen and pSTAT3 are significantly associated with LI suggest that they may represent signaling nodes or biomarkers of pathways common to the processes of postlactational involution and LI. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s10549-017-4413-3) contains supplementary material, which is available to authorized users. Springer US 2017-07-27 2017 /pmc/articles/PMC5645446/ /pubmed/28752190 http://dx.doi.org/10.1007/s10549-017-4413-3 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Preclinical Study Stallings-Mann, Melody L. Heinzen, Ethan P. Vierkant, Robert A. Winham, Stacey J. Hoskin, Tanya L. Denison, Lori A. Nassar, Aziza Hartmann, Lynn C. Visscher, Daniel W. Frost, Marlene H. Sherman, Mark E. Degnim, Amy C. Radisky, Derek C. Postlactational involution biomarkers plasminogen and phospho-STAT3 are linked with active age-related lobular involution |
title | Postlactational involution biomarkers plasminogen and phospho-STAT3 are linked with active age-related lobular involution |
title_full | Postlactational involution biomarkers plasminogen and phospho-STAT3 are linked with active age-related lobular involution |
title_fullStr | Postlactational involution biomarkers plasminogen and phospho-STAT3 are linked with active age-related lobular involution |
title_full_unstemmed | Postlactational involution biomarkers plasminogen and phospho-STAT3 are linked with active age-related lobular involution |
title_short | Postlactational involution biomarkers plasminogen and phospho-STAT3 are linked with active age-related lobular involution |
title_sort | postlactational involution biomarkers plasminogen and phospho-stat3 are linked with active age-related lobular involution |
topic | Preclinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5645446/ https://www.ncbi.nlm.nih.gov/pubmed/28752190 http://dx.doi.org/10.1007/s10549-017-4413-3 |
work_keys_str_mv | AT stallingsmannmelodyl postlactationalinvolutionbiomarkersplasminogenandphosphostat3arelinkedwithactiveagerelatedlobularinvolution AT heinzenethanp postlactationalinvolutionbiomarkersplasminogenandphosphostat3arelinkedwithactiveagerelatedlobularinvolution AT vierkantroberta postlactationalinvolutionbiomarkersplasminogenandphosphostat3arelinkedwithactiveagerelatedlobularinvolution AT winhamstaceyj postlactationalinvolutionbiomarkersplasminogenandphosphostat3arelinkedwithactiveagerelatedlobularinvolution AT hoskintanyal postlactationalinvolutionbiomarkersplasminogenandphosphostat3arelinkedwithactiveagerelatedlobularinvolution AT denisonloria postlactationalinvolutionbiomarkersplasminogenandphosphostat3arelinkedwithactiveagerelatedlobularinvolution AT nassaraziza postlactationalinvolutionbiomarkersplasminogenandphosphostat3arelinkedwithactiveagerelatedlobularinvolution AT hartmannlynnc postlactationalinvolutionbiomarkersplasminogenandphosphostat3arelinkedwithactiveagerelatedlobularinvolution AT visscherdanielw postlactationalinvolutionbiomarkersplasminogenandphosphostat3arelinkedwithactiveagerelatedlobularinvolution AT frostmarleneh postlactationalinvolutionbiomarkersplasminogenandphosphostat3arelinkedwithactiveagerelatedlobularinvolution AT shermanmarke postlactationalinvolutionbiomarkersplasminogenandphosphostat3arelinkedwithactiveagerelatedlobularinvolution AT degnimamyc postlactationalinvolutionbiomarkersplasminogenandphosphostat3arelinkedwithactiveagerelatedlobularinvolution AT radiskyderekc postlactationalinvolutionbiomarkersplasminogenandphosphostat3arelinkedwithactiveagerelatedlobularinvolution |